Development of genital warts after incident detection of human papillomavirus infection in young men

Journal of Infectious Diseases

Volumn 202, Issue 8, 2010, Pages 1181-1184

  Arima, Yuzo ^a   Winer, Rachel L ^a   Feng, Qinghua ^a   Hughes, James P ^a,b   Lee, Shu Kuang ^a   Stern, Michael E ^a   O'Reilly, Sandra F ^a   Koutsky, Laura A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; CONFIDENCE INTERVAL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; ADOLESCENT; ALPHAPAPILLOMAVIRUS; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY; RISK FACTOR; TIME; VIROLOGY;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; COHORT STUDIES; CONDYLOMATA ACUMINATA; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 77957004297     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656368     Document Type: Article

References (13)

1. Giuliano AR, Tortolero-Luna G, Ferrer E, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008; 26(suppl 10):K17-K28.
2. Fleischer AB Jr, Parrish CA, Glenn R, Feldman SR. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis 2001; 28:643-647. (Pubitemid 33055108)
3. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(suppl 3):S3/35-S3/41.
4. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003; 36:1397-1403.
5. Hoy T, Singhal PK, Willey VJ, Insinga RP. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin 2009; 25:2343-2351.
6. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect 2009; 85:499-502.
7. Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009; 9:119.
8. Partridge JM, Hughes JP, Feng Q, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007; 196:1128-1136. (Pubitemid 47580267)
9. Feng Q, Cherne S, Winer RL, et al. Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 2009; 47:547-553.
10. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191:731-738. (Pubitemid 40271061)
11. Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Guris D. Outcomes following incident HPV 6/11/16/18 DNA detection in young men. Paper presented at: 25th International Papillomavirus Conference, 8-14 May 2009; Malmo, Sweden.
12. National Center for Educational Statistics. Recent high school completers and their enrollment in college, by sex: 1960 through 2007. Washington, DC: National Center for Educational Statistics, 2008.
13. Dinh TH, Sternberg M, Dunne EF, Markowitz LE. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm Dis 2008; 35:357-360.